PositoAI

a positivity index

Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights

Latest News

Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc Estimates – FWB:9HA
TradingView · 23 Oct 2026
Elicio Therapeutics Presents Late-Breaking Phase 2 AMPLIFY-7P Results at ESMO Congress 2026 and Announces Simultaneous Publication in Nature Medicine
The Manila Times · 23 Oct 2026
Elicio’s pancreatic cancer vaccine misses primary endpoint By Investing.com
Investing.com India · 23 Oct 2026
Form DEF 14A ELICIO THERAPEUTICS For: 9 October By Investing.com
Investing.com India · 09 Oct 2026
Elicio Therapeutics | DEF 14A: Definitive information statements
Moomoo · 09 Oct 2026
Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026
Elicio Therapeutics · 24 Sep 2026
Elicio to present new pancreatic cancer trial data at ESMO
Investing.com · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.